Ultomiris 25682-0025

Generic: Ravulizumab

Product NDC

25682-0025

Manufacturer: Alexion Pharmaceuticals Inc.
Dosage Form: Solution, Concentrate
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: October 9, 2020
Listing Expires: December 31, 2026
Application: BLA761108

Need to source Ultomiris? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Ravulizumab	300 mg/3mL

Drug Class

Complement Inhibitor [EPC]Complement Inhibitor [EPC]Complement Inhibitors [MoA]

Packaging Options(1)

25682-0025-01

1 VIAL, GLASS in 1 CARTON (25682-025-01) / 3 mL in 1 VIAL, GLASS

View →